Jennifer Shing

Jennifer Shing is a Clinical Research Coordinator at Mayo Clinic, where employment began in April 2023 at the Comprehensive Cancer Center. Prior to this role, Jennifer served as a Technology Specialist at Clark+Elbing LLP from October 2020 to December 2022, and as a Postdoctoral Fellow at AbbVie within Investigative Toxicology and Pathology from September 2017 to October 2020. Jennifer began career contributions as an ORISE Fellow at the FDA's Office of New Drugs from August 2016 to September 2017 and previously held a Postdoctoral Fellow position at Mayo Clinic from July 2015 to July 2016. Academia includes a PhD in Molecular Pharmacology and Experimental Therapeutics from Mayo Clinic Graduate School of Biomedical Sciences (2009-2015) and a BSc in Human Biology: Health and Disease Specialist from the University of Toronto (2005-2009).